People's Hospital of Chongqing
11
5
5
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
9.1%
1 terminated/withdrawn out of 11 trials
0.0%
-86.5% vs industry average
36%
4 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
China Cognition and Aging Study
Role: collaborator
The Chinese Familial Alzheimer's Network
Role: collaborator
Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy
Role: collaborator
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Role: collaborator
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Role: collaborator
Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial
Role: collaborator
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)
Role: collaborator
Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China
Role: collaborator
A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
Role: collaborator
Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG
Role: collaborator
Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study
Role: collaborator
All 11 trials loaded